Custom Gene Synthesis Service Market Projected to Reach $5.3 Billion by 2035 at 8.2% CAGR
If you only eat one bagel today, this is the bagel.
Summary
The Custom Gene Synthesis Service Market is projected to grow from USD 2.41 billion to USD 5.3 billion by 2035, at a CAGR of 8.2% during 2026-2035. Key growth drivers include advancements in genetic research, increased biotechnology investments, rising demand for synthetic biology applications, and the need for tailored gene synthesis in pharmaceuticals and agriculture. The market is shifting toward personalized medicine, innovative agricultural products, and automation/high-throughput synthesis methods.
Key quotes
· 3 pulledThe Global Custom Gene Synthesis Service Market is experiencing significant growth driven by advancements in genetic research, increasing investments in biotechnology, and the rising demand for synthetic biology applications.
A pivotal market driver is the escalating need for tailored gene synthesis solutions in pharmaceuticals, agriculture, and other fields, which is facilitating a shift toward personalized medicine and innovative agricultural products.
The trend toward automation and high-throughput synthesis methods has also gained momentum.
You might also wanna read
Protuoso Biosciences raises $9.5M for AI-designed multifunctional biologic drugs
Protuoso Biosciences, a California-based startup, has raised $9.5 million to advance its AI-designed multifunctional biologics platform. The
longevity.technology·2d ago
Google's Debug program seeks EPA permit to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
bit.ly·2h ago
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years. Th
fox35orlando.com·3h ago
Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·7h ago
Molecular glue approach doubles survival time for aggressive pancreatic cancer patients
Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins
pasadenastarnews.com·8h ago
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
wyss.harvard.edu·11h ago